Staff COVID-19 vaccinations have risen 25 percentage points under CMS mandate
By
Kathleen Steele Gaivin
May 18, 2022
COVID-19 vaccination rates among nursing home staff jumped 25 percentage points nationally thanks in no small part to a CMS mandate imposed earlier this year.
Plant-based recombinant COVID-19 vaccine found to be effective
May 04, 2022
Vaccine efficacy ranged from 69.5% against symptomatic infection to 78.8% against moderate-to-severe disease.
Natural COVID-19 immunity produces protection similar to vaccines
Apr 27, 2022
Similar natural protection was seen against mild and severe disease.
Moderna says its combo vaccine effective against omicron
Apr 19, 2022
The company says the combination vaccine triggers antibodies capable of fighting several variants, including beta and omicron.
Adverse effects generally mild after BNT162b2 mRNA booster in over 60s
Apr 18, 2022
Thirty percent of those aged 60 years or older receiving a booster reported at least one adverse event; few sought medical attention.
Fourth dose of BNT162b2 offers protection against severe COVID-19
Apr 08, 2022
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose of the Pfizer–BioNTech vaccine; protection against the infection waned.
Vaccination offers extra protection after SARS-CoV-2 infection
Apr 06, 2022
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination.
FDA panel meets to craft future vaccine strategy
Apr 06, 2022
No official vote is planned, and no specific vaccine products will be discussed.
Booster strategies after Janssen shot increased protection against omicron
Mar 30, 2022
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses.
As second COVID-19 booster dose is approved, senior living calls for help
By
Kimberly Bonvissuto
Mar 30, 2022
As public health officials brace for a potential surge in coronavirus cases due to the BA.2 variant, the federal government on Tuesday approved a second COVID-19 booster dose for higher-risk individuals.